Background: Increased carotid intima media thickness (CIMT) is frequently associated with established modifiable and non-modifiable cardiovascular risk factors, and is thought to be an independent predictor of ischemic cerebrovascular and cardiac events. The presence of carotid plaque is considered an established feature of atherosclerosis. There exist few longitudinal data on the predictive role of CIMT in the occurrence of carotid plaque. Methods: We restudied the survivors of a cohort of the San Daniele Project, a large randomized general population study, investigated in 1990 regarding the prevalence and determinants of carotid atherosclerosis. Using ultrasonography, we determined in 1,193 subjects (548 men and 645 women), the common carotid IMT and the presence of non-stenotic and stenotic plaque. Results: In 795 subjects without plaques or previous ischemic events at baseline, we found in multivariate analysis that CIMT ≧1 mm, age, hypertension and history of smoking are significant predictive elements of the occurrence of a new carotid plaque. The incremental probability of plaque occurrence is greater in midlife. CIMT and age are the most predictive risk factors with ORs of 3.66 (95% CI 1.4–9.4) and 3.02 (95% CI 2.4–3.7), respectively. The ORs for hypertension and smoking account for 1.5 (95% CI 1.1–3.4) and 1.7 (95% CI 1.1–2.8), respectively. Conclusions: Age, hypertension, history of smoking and B-mode detection of CIMT increases in subjects without carotid atherosclerosis and free of previous vascular events predict the occurrence of carotid atherosclerotic plaque.

Keywords:
Atherosclerosis, Prevention, Intima media thickness, Risk factors, Ultrasonography
1.
Wilson PWF, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837–1847.
2.
Conroy RM, Pyörälä K, Fitzgerald AP et al: on behalf of the SCORE project group. Estimation of ten year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987–1003.
3.
Giampaoli S, Vanuzzo D, et al (Editors): Atlante Italiano delle Malattie Cardiovascolari. 2a Edizione. (Italian Atlas of Cardiovascular Diseases. 2nd Edition) Ital Heart J 2004;5(suppl 3):1S–101S. (text in Italian and English, free download at http://www.italheartj.org/ March 2004 suppl. 3).
4.
Fathi R, Marwick TH: Noninvasive tests of vascular function and structure: why and how to perform them. Am Heart J 2001;141:694–703.
5.
Greenland P, Abrams J, Aurigemma GP, et al: Prevention Conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation 2000;101:e16–e22.
6.
Salonen JT, Salonen R: Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb 1991;11:1245–1249.
7.
Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE: Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997;96:1432–1437.
8.
Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR, Clegg LX: Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987–1993. Am J Epidemiol 1997;146:483–494.
9.
Mackinnon AD, Jerrard-Dunne P, Sitzer M, Buehler A, von Kegler S, Markus HS: Rates and determinants of site-specific progression of carotid artery intima-media thickness: the carotid atherosclerosis progression study. Stroke 2004;35:2150–2154.
10.
Fox CS, Polak JF, Chazaro I, Cupples A, Wolf PA, D’Agostino RA, O’Donnell CJ: Framingham Heart Study: Genetic and environmental contributions to atherosclerosis phenotypes in men and women: heritability of carotid intima-media thickness in the Framingham Heart Study. Stroke 2003;34:397–401.
11.
O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr: Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999;340:14–22.
12.
Touboul PJ, Elbaz A, Koller C, Lucas C, Adrai V, Chedru F, Amarenco P: Common carotid artery intima-media thickness and brain infarction: the Etude du Profil Genetique de l’Infarctus Cerebral (GENIC) case-control study. The GENIC Investigators. Circulation 2000;102:313–318.
13.
Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu CR, Liu CH, Azen SP: The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 1998;128:262–269.
14.
Vemmos KN, Tsivgoulis G, Spengos K, Papamichael CM, Zakopoulos N, Daffertshofer M, Lekakis JP, Mavrikakis M: Common carotid artery intima-media thickness in patients with brain infarction and intracerebral haemorrhage. Cerebrovasc Dis 2004;17:280–286.
15.
Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW: A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1995;92:1355–1374.
16.
Glagov S, Bassiouny HS, Giddens DP, Zarins CK: Pathobiology of plaque modeling and complication. Surg Clin North Am 1995;75:545–556.
17.
Joakimsen O, Bønaa KH, Mathiesen EB, Stensland-Bugge E, Arnesen E: Prediction of mortality by ultrasound screening of a general population for carotid stenosis. The Tromsø Study. Stroke 2000;31:1871–1876.
18.
Spence JD, Eliasziw M, DiCicco M, Hackam DG, Galir R, Lohmann T: Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy. Stroke2002;33:2916–2922.
19.
Touboul PJ, Labreuche J, Vicaut E, Amarenco P, GENIC Investigators: Carotid intima-media thickness, plaques, and Framingham Risk Score as independent determinants of stroke risk. Stroke 2005;36:1741–1745.
20.
Zureik M, Ducimetiere P, Touboul PJ, Courbon D, Bonithon-Kopp C, Berr C, Magne C: Common carotid intima-media thickness predicts occurrence of carotid atherosclerotic plaques: longitudinal results from the Aging Vascular Study (EVA) study. Arterioscler Thromb Vasc Biol 2000;20:1622–1629.
21.
Johnsen SH, Fosse E, Joakimsen O, Mathiesen EB, Stensland-Bugge E, Njølstad I, Arnesen E: Monocyte Count Is a Predictor of Novel Plaque Formation. A 7-Year Follow-up Study of 2610 Persons Without Carotid Plaque at Baseline. The Tromsø Study. Stroke 2005;36:715–719.
22.
Prati P, Vanuzzo D, Casaroli M, Di Chiara A, De Biasi F, Feruglio GA, Touboul PJ: Prevalence and determinants of carotid atherosclerosis in a general population. Stroke 1992;23:1705–1711.
23.
Tosetto A, Prati P, Baracchini C, Manara R, Rodeghiero F: Age-adjusted reference limits for carotid intima-media thickness as better indicator of vascular risk: population-based estimates from the VITA project. J Thromb Haemost 2005;3:1224–1230.
24.
Prati P, Vanuzzo D, Casaroli M, Mos L, Pilotto L, Munini E, Ruscio M, Nobile G, Salsa F: The San Daniele 2 Project: protocol description and population characteristics. Ital Heart J 2003;4:803–809.
25.
Touboul PJ, Hennerici MG, Meairs S, Adams S, Amarenco P, Desvarieux M, Ebrahim S, Fatar M, Hernandez Hernandez R, Kownator S, Prati P, Rundek T, Taylor A, Bornstein N, Csiba L, Vicaut E, Woo KS, Zannad F:Mannheim intima-media thickness consensus. Cerebrovasc Dis 2004;18:346–349.
26.
WHO MONICA Project: MONICA Manual. (1998–1999). Available from URL: http://www.ktl.fi/publications/monica/manual/index.htm, URN:NBN:fi-fe19981146.
27.
Giampaoli S, Vanuzzo D, et al: (Editors). Atlante Italiano delle Malattie Cardiovascolari. 1a Edizione. (Italian Atlas of Cardiovascular Diseases. 1st Edition) Ital Heart J 2003;4 (suppl 4):1S–121S. (text in Italian and English, free download at http://www.italheartj.org/ April 2003 suppl 4).
28.
Touboul PJ, Prati P, Scarabin PY, Adrai V, Thibout E, Ducimetiere P: Use of monitoring software to improve the measurement of carotid wall thickness by B-mode imaging. J Hypertens Suppl 1992;10:S37–S41.
29.
Ebrahim S, Papacosta O, Whincup P, Wannamethee G, Walker M, Nicolaides AN, Dhanjil S, Griffin M, Belcaro G, Rumley A, Lowe GD: Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke 1999;30:841–850.
30.
Selvin E, Coresh J, Golden SH, Boland LL, Brancati FL, Steffes MW: Atherosclerosis risk in communities study. Glycemic control, atherosclerosis, and risk factors for cardiovascular disease in individuals with diabetes: the atherosclerosis risk in communities study. Diabetes Care 2005;28:1965–1973.
31.
Hollander M, Bots ML, Del Sol AI, Koudstaal PJ, Witteman JC, Grobbee DE, Hofman A, Breteler MM: Carotid plaques increase the risk of stroke and subtypes of cerebral infarction in asymptomatic elderly: the Rotterdam study. Circulation 2002;105:2872–2877.
32.
Van der Meer IM, Bots ML, Hofman A, del Sol AI, van der Kuip DA, Witteman JC: Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam Study. Circulation 2004;109:1089–1094.
© 2006 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.